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nma, a novel gene, was isolated by using a subtractive 
hybridization technique in which the gene expression was 
compared in a panel of human melanoma cell lines with 
different metastatic potential, nma mRNA expression ( 1.5 kb) is 
high in poorly metastatic human melanoma cell lines and 
xenografts and completely absent in highly metastatic human 
melanoma cell lines. Fluorescence in situ hybridization com­
bined with the analysis of a panel of human-rodent somatic cell 
hybrids indicated that the nma gene is located on human 
chromosome 10, in the region pi I.2~pl2.3. Sequence analysis 
of nma showed no homologies with other known genes or 
proteins, except for several partially sequenced cDNAs. The 
predicted amino acid sequence suggests that the protein en­
coded by nma contains a transmembrane domain. Expression of 
nma is high in human kidney medulla, placenta and spleen, low 
in kidney cortex, liver, prostate and gut and absent in lung and 
muscle. Whereas nma is not expressed in normal skin tissue, 
expression is high in melanocytes and in 3 out of 11 melanoma 
metastases tested.
© 1996 Wiley-Liss, Inc.
Metastatic melanoma is one of the most invasive cancers, 
the incidence of which has rapidly increased in the past 
decade. The process of metastasis is thought to be character­
ized by subsequent distinct stages as defined by Clark et al 
(1984) and Herlyn et ai (1987), and eventually enables a 
primary tumor to spread and colonize at secondary sites. A set 
of biological markers defining unequivocally each stage of 
tumor development is lacking. New markers are thus sought 
for better diagnosis and therapeutic strategies. They may also 
lead to a better understanding of the tumor biology of 
melanoma.
In cultured human melanocytic cells, several tumor markers 
have been defined that are possibly indicative for metastatic 
potential (Weterman et al, 1994). Some of these markers may 
)e very useful in clinical practice as well as in studies of tumor 
biology. Several strategies have been used to isolate tumor 
progression markers. The use of monoclonal antibodies 
(MAbs), in particular, was successful in the isolation of 
membrane associated proteins, such as membrane receptors 
and adhesion molecules (Real et ai, 1985), A number of 
melanoma markers represent (potential) tumor suppressor 
activities, e.g., nm23 (Leone et ai, 1991) and p i 6 (Kamb et ai,
1994).
In the last few years, we have identified several potential 
progression markers, e.g., calcyclin (Weterman et ai, 1992), 
thymosin-|310 (Weterman et ai, 1993), nmb (Weterman et ai,
1995) and nma (this report), by using differential and subtrac­
tive hybridization techniques. Calcyclin and thymosin-plO are 
expressed in highly metastatic human melanoma cell lines, 
whereas nma and nmb are expressed in poorly metastatic 
human melanoma cell lines.
The absencc of expression of nma and nmb in highly 
metastatic cell lines does not imply a role in tumor progression. 
It merely indicates that these markers are part of the pheno­
type of a non-metastasizing cell line. Because this phenotype
may be relevant for tumor biology, we now present a character­
ization of the nma gene.
MATERIAL AND METHODS
Human melanoma cell lines 1F6, 530, BLM, MV3 and MV1 
(van Muijen et ai, 1991a, b, c) were cultured as described by 
Weterman et ai (1992). In this panel of cell lines, BLM and 
MV3 represent the highly metastatic ccll lines, Le., those in 
which metastases occur in more than 50% of the tumor- 
bearing mice. 1F6, 530 and MV1 produced metastases in less 
than .10% of the tumor-bearing mice, representing the poorly 
metastatic cell lines (van Muijen et ai, 1991a); 3 x 106 cells 
were used for s.c. inoculation into nude mice {nutmu BALB/c; 
Bomholtgaard, Ry, Denmark).
Excision and processing of the human tissues was performed 
as described by Weterman et ai (1995).
RNA isolation and Northern blot analysis
Total RNA was isolated using the lithium-urca procedure 
described by Auffray and Rougeon (1980). RNA oligo- 
deoxythymidine selections were performed using oligo- 
deoxythymidine columns (type II; Collaborative Research, 
Bedford, MA). Total RNA (10 fig) was glyoxylatcd (McMastcr 
and Carmichael, 1977), size fractionated on 1% agarose gels 
and blotted onto Hybond N-pIus filters (Amersham, Ayles­
bury, UK). Northern blots were hybridized according to 
Church and Gilbert (1984), with the addition of 0.1 mg 
denatured herring sperm DNA/ml of hybridization mixture. 
To confirm that equal amounts of RNA were loaded in each 
lane, the blots were hybridized afterwards to an 18S ribosomal 
probe.
Construction of cDNA and subtraction libraries
cDNA libraries were constructed from 5 |xg of oligo- 
deoxythymidine selected RNA using a cDNA cloning kit 
(Invitrogen, San Diego, CA) or a XZAP cDNA synthesis kit 
(Stratagene, La Jolla, CA). Construction of the MV3-MV1 
subtraction library with a subtractor kit (Invitrogen) was 
performed as described before (Weterman et ai, 1993). The 
poorly metastatic human melanoma ccll line 530 was used for 
the construction of the 530 XZAP cDNA library.
DNA probes and hybridization o f cDNA and genomic libraries
DNA probes were radiolabeled using the random prime 
method as recommended by Boehringer Mannheim (Ger­
many). Hybridization of cDNA libraries and the human fetal 
brain genomic library (kindly provided by Mr. A. van Bok­
hoven, Department of Urology, Nijmegen) was performed For
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F i g u r e  1 -  Northern blot analysis of human melanoma cell lines 
and xenografts; 10 jig of total RNA were loaded in each lane. 
Lanes A-E, cell lines; Lanes F-J, xenografts. Lanes A and F, 
BLM; B and G, MV3; C and H, MV1; D and I, 1F6; E and J, 530. 
The blot was hybridized to radiolabeled 1.5 kb nma cDNA, The 
m.w. marker was Hindlll digested XDNA. As a control, an IBS 
ribosomal hybridization is shown.
16 hr in 5x SSPE, 5x Dcnhardt’s and 0.5% SDS in the 
presence of 0.1 mg/ml denatured herring sperm DNA at 65°C. 
Filters were washed in a stringent manner, using decreasing 
salt concentrations (2 x and l x  SSPE/0,1% SDS) at room 
temperature and 65°C, respectively.
Chromosomal DNA isolation and Southern blot analysis
Chromosomal DNA was isolated using the method of Blin 
and Stafford (1976). DNA was digested with EcoRI, and 10 pig 
was size fractionated on 1% agarose gels. DNA was trans­
ferred to Hybond N-pIus filters and hybridized as described 
previously for Northern blot analysis. To confirm that equal 
amounts of DNA were loaded in each lane, blots were 
hybridized afterwards to a chromosome IB-specific centro- 
meric probe. Abnormalities involving chromosome 18 have not 
been described in relation to melanoma.
DNA sequencing and computer analysis
DNA fragments were sequenced according to the dideoxy 
method described by Sanger et al (1980) using a Sequenase 
sequencing kit (USB, Cleveland, OH), Large fragments were 
sequenced by constructing a set of deletion clones using 
exonuclease III (Erase-a-base kit, Promega, Madison, WI). 
Searches for known DNA sequences were performed using the 
GenBank and EMBO databases (Dcvereux et a l , 1984; Pear­
son and Lipman, 1988). DNA sequence analysis, including 
searches for motifs, alignments and structure predictions, was 
performed using the CAMMSA programs MOTIFS, PILEUP, 
CLUSTAL V, BESTFIT, PEPTIDESTRUCTURE, PLOT- 
STRUCTURE and MEMBRANE PROPENSITY, which are 
all part of the Wisconsin Package V.7.0 (DevcrcuxtV al, 1984).
Determination o f the transcription start site o f the nma gene 
by SI mapping
Nuclease SI mapping was performed using the method of 
van Lcen et al. (1986). Briefly, 50 fig of total 530 RNA or yeast 
tRNA was hybridized with 1 x 106 cpm of a 32P-labcled 
antisense ssDNA probe derived from the human genomic nma 
subclone pWD117. Subclone pWD117 consists of a 418 bp 
Aval DNA restriction fragment subcloncd in pGEM-3zf(-). 
Nucleotide positions 304 to 418 of this Aval fragment corre­
spond to positions 1 to 115 of the human nma cDNA sequence. 
This fragment also contains a putative TATA and CAAT box. 
The insert was labeled using the method of Sanger et al (1980),
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F i g u r e  2  -  Complete nucleotide sequence of nma (GenBank 
accession number U23070) and translated predicted protein. A 
putative polyadenylation signal is marked by asterisks. Startin, 
points of exons II and III (see also Fig. 4 and the Results section 
are also indicated.
and a single stranded DNA probe was isolated following SacI 
digestion and electrophoresis on a 4% polyacrylamide/7 M 
urea gel. Annealing was performed at 40°C overnight. Nucle­
ase SI (Boehringcr Mannheim) was used at 1000 units/ml for 1 
hr at 37°C. The remaining product was elcctrophorcsed on a 
6% polyacrylamide/7 M urea gel.
ChromosonuiI loca liza tion o f the nma gene
The initial chromosomal assignment of the nma gene was 
carried out by using a panel of monochromosomal human-
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F ig u r e  3  -  Predicted characteristics of the protein encoded by nma. The upper panel shows a Kyte and Doolittle (1982) prediction of 
hydrophilicity. Hydrophobic regions are indicated by negative values.
rodent somatic cell hybrids (Coriell Repository, Camden, NJ) 
and the complete nma cDNA clone as a probe for Southern 
blot analysis. Further refinement of the localization was 
obtained through fluorescence in situ hybridization (FISH) on 
normal human metaphase spreads using the complete nma-1 
genomic clone as a probe. Briefly, probe DNA was nick 
translated with digoxigenin-ll-dUTP (Boehringer Mann­
heim). For efficient hybridizations, 10 ng of labeled probe were 
applied under a 20 x 20 mm carrier slip onto normal 
lymphocyte-derived metaphase spreads. Visualization of the 
hybridization signals was accomplished using fluorescein- 
conjugated sheep anti-digoxigenin and fluorescein-conjugated 
donkey anti-sheep antibodies (Jackson Immunoresearch, West 
Grove, PA). Slides were immersed in antifade solution supple­
mented with DAJPI (Sigma, St. Louis, MO) for counterstaining 
of the chromosomes. Digital images were captured using a 
cooled CCD-camera (Photometries, Tucson, AZ) coupled to a 
Macintosh computer.
cDNAs (150 to 500 bp) with accession numbers D25985, 
T73919, T85484, T90372, Z39I58 and Z41678.
RESULTS
Cloning and characterization o f a differentially expressed nma 
cDNA clone
During the isolation of cDNA clones differentially expressed 
in a panel of poorly metastatic versus highly metastatic human 
melanoma cell lines, 2 novel genes, designated nmb (Weter- 
man et a l , 1995) and nma, were identified that showed 
expression in the poorly metastatic human melanoma cell lines 
1F6, 530 and MV1. The expression of nma is shown in Figure
1. nma mRNA expression is high in the poorly metastatic 
human melanoma cell lines 1F6, 530 and MV1 and derived 
xenografts. Expression was not detected in the highly meta­
static cell lines BLM and MV3 and xenografts derived from 
these cell lines.
Sequencing revealed that nma represents a novel gene. 
Screening of a cDNA library derived from the poorly meta­
static human melanoma cell line 530 resulted in the isolation of 
the nma cDNA clone pWD58. An SI mapping experiment 
described below indicates that clone pWD58 contains the 
complete cDNA. The nma cDNA sequence with a putative 
polyadenylation signal, translation start site and open reading 
frame (260 amino acids) is shown in Figure 2. A consensus 
signal cleavage site located downstream of amino acid 27 (Glu) 
indicates that the predicted nma protein contains a signal 
sequence. A glycosylation site and a Kyte and Doolittle (1982) 
prediction of hydrophilicity are schematically depicted in 
Figure 3. The predicted amino acid sequence contains a 
transmeinbrane domain indicating, together with the other 
data, that nma codes for a transmembrane protein.
Sequence comparison showed no similarities with known 
genes or proteins, except for several partially sequenced
Isola tion and partial sequencing o f a genomic clone containing 
the nma gene
Screening of a human fetal brain genomic library with nma 
cDNA clone pWD58 yielded 1 positive clone with an insert of 
approximately 30 kb. Characterization of this genomic clone 
nma-1 was performed by producing a set of subclones using 
several restriction cndonucleascs. A 9 kb BamHI fragment was 
isolated that hybridized with both a 5' and a 3' nma cDNA 
probe and, thus, contained the complete coding sequence. 
Subclones of this 9 kb BamHI fragment were partially se­
quenced in order to locate exon-intron junctions. The gene 
consists of 3 exons, 448,288 and 784 bp, respectively, separated 
by 2 introns of 3 kb and 435 bp (Fig. 4; GenBank accession 
numbers for exon-containing sequences I, U29188; II and III, 
U29189).
The 9 kb BamHI nma genomic fragment is flanked by 2 
EcoRI restriction sites and also contains 1 EcoRI restriction 
site between exons II and III, and 1 EcoRI site in exon III (Fig. 
4). When hybridizing a Southern blot containing EcoRI 
digested genomic DNA from human melanoma cell lines to a 
complete nma cDNA probe, 3 bands arc expected to hybridize. 
In Figure 5, the 3 EcoRI bands are indicated by arrows. An 
additional band of approximately 4 kb is visible in melanoma 
cell line BLM that may be the result of cross hybridization.
S'l mapping was performed with a genomic nma antisensc 
ssDNA probe overlapping the putative transcription start site 
and total RNA from t ic poorly metastatic melanoma cell line 
530, to define precisely the 5' transcription start site of the nma 
gene. Besides the first 115 nucleotides of the cDNA sequence, 
this genomic nma DNA fragment also contains a putative 
TATA and CAAT box. A transcription start region correspond­
ing to protected transcripts of 113 to 115 nucleotides long is 
visible in Figure 6, indicating that 2 or 3 alternative transcrip­
tion start sites are used.
Chromosom al I oca liza tion o f th e n m a gen e
The initial chromosomal assignment of the nma gene was 
carried out via Southern blot analysis of a well-defined panel of 
monochromosomal huinan-rodcnt somatic cell hybrids with 
nma cDNA pWD58 as a probe. A single hybrid revealed a 
human-specific hybridizing fragment (not shown). This hybrid 
contains chromosome 10 as its only human constituent, thus 
mapping the gene to this human chromosome. Further refine­
ment of the localization was obtained by using FISH with the 
genomic nma-1 clone. In this case, hybridization signals were 
observed in several (telomeric) chromosomal regions (not
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F igure  4  -  Schematic map of the nma gene, (a) The schematic map of nma with the major restriction sites. The black boxes in the gene 
correspond lo the 3 exons. B, BamHI; E, EcoRI; H, Hindlll; S, SacI; X, Xbal. (b) Nucleotide sequences of exon-intron junctions of 
exons I, II and III. Lowercase letters indicate intron sequences, whereas exon sequences are indicated by capitals (GenBank accession 
numbers for exon-containing sequences I, U29188; II and III, U29189).
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F igure  5 -  Southern blot analysis of several human melanoma 
cell lines; 1.0 jxg of EcoRI digested chromosomal DNA were 
loaded in each lane. Lane A, MV1; Lane B, 530; Lane C, 1F6; 
Lane D, BLM; Lane E, MV3 DNA digested with EcoRI. The blot 
was hybridized to radiolabeled 1.5 kb nma cDNA. Hybridizing 
bands are indicated with arrows. The m.w. marker was I-Iindlll 
digested A.DNA. As a control, a chromosome 18-specific centro- 
meric hybridization is shown (3 bands of approximately 20,1.3 and 
0.6 kb). Abnormalities involving chromosome 18 have not been 
described in relation to melanoma.
shown). A specific signal was observed on the short arm of 
chromosome 10, in the region pi 1 .2—p i2.3, We conclude that 
the nma gene maps to this region. A number of other signals 
may be due to cross hybridization and/or the presence of other 
nmaAikc sequences in the human genome.
Expression o f  nma in human melanocytic lesions
A Northern blot containing several human melanocytic 
lesions was screened for nma expression (Fig. 7). Whereas nma
F ig u r e  6 -  Determination of the 5 ' transcription start site of the 
nma gene by Si mapping. An antisense nma ssDNA genomic 
subclone containing the 5' untranscribed region with putative 
TATA and CAAT boxes and flanking the first 115 nucleotides of 
the cDNA sequence was hybridized with 50 jxg of 530 total RNA 
or yeast tRNA. Upon treatment of the hybrid with nuclease SI, the 
product was analyzed under denaturing conditions (indicated with 
an arrow). Lane I, 530 total RNA; lane II, yeast tRNA; lane III, 
intact undigested ssDNA probe. A portion of the corresponding 
dideoxy sequencing reactions is shown at the left.
(indicated with an arrow) is highly expressed in melanocytes 
and in 3 out of 11 melanoma métastasés, expression in the 
other métastasés is low or absent. Remarkably, 3 out of 4 
métastasés with strong pigmentation (Lanes I, J, M) show high 
nma expression levels, nma does not seem to be expressed in 
normal skin tissue (Lane B). The upper 1.9 kb band may be the 
result of cross-hybridization of nma with the 1.9 kb 18S rRNA 
(compare with control hybridization).
Expression o f  nma in human organs
The expression of nma in several human organs was tested 
using a Northern blot containing kidney cortex and kidney 
medulla, lung, muscle, liver, placenta, spleen, prostate and gut 
total RNA (Fig, 8). nma is expressed at high levels in kidney
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F ig u r e  7 -  Northern blot analysis of human cutaneous melano- 
cytic lesions; 10 fig of total RNA were loaded in each lane. Lane 
A, melanocytes; Lane B, normal skin tissue (obtained from 
melanoma patients); Lane C, pooled dysplastic naevi (6 lesions 
from 6 patients); Lane D, xenograft derived from radial growth 
phase (RGP); Lane E, xenograft derived from vertical growth 
phase (VGP); Lanes F-P, melanoma metastases. Pigmentation 
was strong in the metastases in lanes I, J, L and M, weak in lanes F 
and N and absent in lanes G, H, K, O and P. The blot was 
hybridized to radiolabeled 1.5 kb nma cDNA. Expression of nma is 
indicated with an arrow. The m.w. marker was Hindlll digested 
XDNA. As a control, an 18S ribosomal hybridization is shown,
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F ig u r e  8 -  Northern blot analysis of several human organs; 10 
jig of total RNA were loaded in each iane. Lane A, kidney cortex; 
Lane B, kidney medulla; Lane C, lung; Lane D, smooth muscle; 
Lane E, liver; Lane F, placenta; Lane G, spleen; Lane H, prostate; 
Lane I, colon. The blot was hybridized to radiolabeled L5 kb nma 
cDNA. The m.w. marker was Hindlll digested XDNA. As a 
control, an 18S ribosomal hybridization is shown.
medulla, placcnta and spleen, and at moderate levels in kidney 
cortex, liver, prostate and gut. Expression is absent in lung and 
muscle. These results indicate that nma is not melanocyte- 
specific.
human melanoma cell lines 1F6, 530 and MV1 and derived 
xenografts, and completely absent in the highly metastatic 
melanoma cell lines BLM and MV3 (Fig. 1). The differences in 
RNA expression of nma between poorly and highly metastatic 
melanoma cell lines cannot be explained by major chromo­
somal rearrangements, as demonstrated by Southern blot 
analysis (Fig. 5). The observed differences in nma mRNA 
expression may, therefore, reflect differences in promoter 
activity of the nma gene.
Sequence analysis revealed that nma is a new gene. The 
presence of a signal sequence and a hydrophobic area of 25 
amino acid residues (positions 151 to 175) bordered by 
charged residues indicates that the gene encodes a transmem- 
brane protein.
The nma gene is located on human chromosome 10 in the 
region pll.2-pl2,3 (results not shown). Loss of heterozygosity 
(LOH) of chromosome 10 in relation to malignant melanoma 
has already been described. Isshiki et a l (1993) concluded 
from their results that a tumor suppressor gene may be located 
on lOq, although allelic losses on lOp were also found.
Although its expression pattern in cell lines and derived 
xenografts offers the perspective that nma could be a potential 
marker for early stages of melanoma progression (Fig. 1), its 
presence in a considerable number of human melanoma 
metastasis lesions is not in line with this suggestion (Fig. 7). 
Other (potential) early progression markers, notably nm23 and 
also nmb, display expression profiles similar to that of nma. 
Experimental evidence is available in support of a metastasis 
suppressor function for the nm23 gene (Leone et al, 1991) and 
an nmb clone encoding an N-terminally truncated product 
(Weterman et al., 1995). One could speculate that genes like 
ww23, nmb and also nma may be involved in attenuating 
metastatic properties of melanoma cells. Tumor progression 
may require that these genes are (temporarily) switched off in 
the course of metastasis but turned on again later in a 
secondary, distantly growing tumor. Alternatively, their expres­
sion may only partially inhibit the metastasis. Evidence for a 
transient role of a presumed suppressor of metastasis is given 
by the experiments of Florenes et al. (1992). They demon­
strated that the level of nm23 mRNA was significantly lower in 
tumors from patients with a short interval between primary 
diagnosis and the appearance of metastases than in those with 
more prolonged relapse-free intervals. This observation was 
explained by assuming that the expression of nm23 in metasta­
ses is inversely correlated with aggressive behavior. This 
conclusion was strengthened by Xerri et a l (1994) and Caligo 
et al (1994), who found a correlation between high expression 
of nm23 in patients with a high overall survival following 
metastasis resection and in cell lines derived from these 
metastases. It is possible that nma and nmb follow the same 
pattern as nm23 does and, therefore, arc found in some but not 
all metastases. Although clinical data were available on the 
melanoma metastases used in this study, no final conclusions 
can be drawn because of their small number.
Expression of nma in several human organs indicates that 
the expression is not melanocyte-specific: nma is expressed at 
variable levels in most organs tested, except in lung and muscle 
(Fig. 8).
Further characterization of nma, especially of its biological 
functions, should eventually clarify its role in melanoma 
metastasis.
DISCUSSION
Our report describes the characterization of nma, a novel 
gene, whose expression is inversely correlated with the meta­
static potential of a panel of human melanoma cell lines and 
xenografts, nma is highly expressed in the poorly metastatic
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